Myrcludex B

Create: 12/10/2018

Expired Date:	never
Category:	Health&Medical&Pharmaceutical
Message:	Myrcludex B is an experimental drug for the treatment of hepatitis B and D. The hepatitis B virus uses its surface lipopeptide pre-S1 for docking to mature liver cells via their sodium/bile acid cotransporter (NTCP) and subsequently entering the cells. Myrcludex B is a synthetic N-acylated pre-S1 that can also dock to NTCP, blocking the virus's entry mechanism. https://www.creative-peptides.com/product/myrcludex-b-item-10-101-139-34585.html






City:	Shirley[US]
Location:

Aug 09 2019	HLA-A_24_02 CMV pp65 tetramer-QYDPVAALF-PE labeled	504
Aug 09 2019	H-2Db LCMV gp33 tetramer-KAVYNFATC-APC labeled	521
Aug 09 2019	H-2Kb TRP-2 tetramer-SVYDFFVWL-PE labeled	490
Aug 09 2019	H-2Db WT1 tetramer-RMFPNAPYL-PE labeled	417
Aug 09 2019	H-2Kb HBV core tetramer-MGLKFRQL-APC labeled	499
Aug 09 2019	T-Select H-2Kb Negative (SIY) tetramer-SIYRYYGL-PE labeled	470
Aug 09 2019	T-Select H-2Kb MuLV p15E tetramer-KSPWFTTL-PE labeled	504
Aug 09 2019	T-Select H-2Kb OVA tetramer-SIINFEKL-APC labeled	534
Aug 09 2019	T-Select HLA-A_24_02 survivin-2B tetramer-AYACNTSTL-APC labeled	469
Aug 09 2019	T-Select HLA-A_02_01 CMV pp65 tetramer-NLVPMVATV-PE labeled	502